A Comparative Study of Midazolam and Target-Controlled Propofol Infusion in the Treatment of Refractory Status Epilepticus.

Indian J Crit Care Med · 2018 · PMC6020637 · PMID 29962746

Europe PMC DOI

hedged sentence

0.0890

closest p · 1.8× alpha

0.0890

boldest claim

The sentences

trending toward significanceP = 0.089so close (0.05 < p ≤ 0.1)

Inotropic requirement was higher in the propofol group (81.8%) as compared to the midazolam group (41.7%) with difference trending toward significance ( P = 0.089).

also in 580 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.